BreezeBio
Develops genetic medicines enabled by precise, non-viral nanoparticle delivery across tissues
$60MSeries B
Role not disclosedYI
Yuanta Investment
Activity from announced rounds
Activity in this selectionabu-dhabi-investment-authority-29036a40
- Rounds participated in
- 2
- Confirmed lead rounds
- — 2 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $89M 2 disclosed · full round size, not this investor’s share